Skip to main content
Premium Trial:

Request an Annual Quote

Veracyte Prices $51.3M Public Offering

NEW YORK (GenomeWeb) – Veracyte late on Wednesday priced its previously announced public offering of 5 million shares of its common stock at $10.25 per share to raise an anticipated $51.3 million in gross proceeds.

The South San Francisco, California-based developer of genomics-based diagnostics expects the offering to close on or about July 30 and has granted its underwriters a 30-day option to purchase up to an additional 750,000 shares at the public offering price, less underwriting discounts and commissions.

Leerink Partners and William Blair are the joint book-running managers for the offering. BTIG is the lead manager.

Veracyte said proceeds will go toward working capital and other general corporate purposes. It may also use proceeds to acquire or invest in complementary businesses, technologies, or other assets.

The firm currently offers diagnostic tests for thyroid cancer, lung cancer and idiopathic pulmonary fibrosis. This week its CEO Bonnie Anderson discussed the company's plans in the pharmaceutical space and said that its growing database of transcriptome data could drive future deals with biopharmaceutical companies interested in developing precision medicine therapies.

The company also reported a 24 percent year-over-year increase in its Q2 revenues.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.